Dr. Max Health is an ML/AI-powered preventive medicine platform for physicians. We analyze longitudinal blood panels to forecast biomarker trends and surface early health risk signals — evidence-based, and built with clinical rigor.
Dr.MaxHealth is a product of DMH Software UG (haftungsbeschränkt), Hamburg, Germany.
Roadmap: our platform uses GPU acceleration for biomarker trajectory forecasting, clinical retrieval and reranking, inference prototyping, and privacy-preserving multi-site (federated) learning.
Funding: Bootstrapped by the founders with EUR 25,000 of personal capital and awarded a EUR 75,000 InnoFounder grant by IFB Hamburg (Hamburgische Investitions- und Förderbank) via the InnovationsStarter / InnoFounder programme in 2025.